Fibroblast growth factor 19 meets mammalian target of rapamycin: A mitogenic Tête‐à‐Tête under consideration

E-ISSN： 1527-3350|64|4|1028-1030

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.64, Iss.4, 2016-10, pp. : 1028-1030

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Mechanistic target of rapamycin complex 1 is an essential mediator of metabolic and mitogenic effects of fibroblast growth factor 19 in hepatoma cells

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1289-1301

John Wiley & Sons Inc

Access to resources Recommend Favorite

Une toute nouvelle tête pour l’ancêtre des vertébrés à mâchoires

By Casane Didier Laurenti Patrick

Médecine/sciences, Vol. 30, Iss. 1, 2014-01 ,pp. : 38-40

Edp Sciences

Access to resources Recommend Favorite

Commentary: fibroblast growth factor 19 in patients with bile acid diarrhoea

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 38, Iss. 10, 2013-11 ,pp. : 1320-1321

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fibroblast Growth Factor Receptor 1 as a Target for the Therapy of Renal Cell Carcinoma

Oncology, Vol. 88, Iss. 6, 2015-0 ,pp. : 321-331

Karger

Access to resources Recommend Favorite

Mammalian Target of Rapamycin as a Rational Therapeutic Target for Breast Cancer Treatment

Oncology, Vol. 84, Iss. 1, 2012-10 ,pp. : 43-56

Karger

Access to resources Recommend Favorite